Nothing Special   »   [go: up one dir, main page]

Muckenhuber et al., 2024 - Google Patents

IL-6 inhibition prevents costimulation blockade-resistant allograft rejection in T cell-depleted recipients by promoting intragraft immune regulation in mice

Muckenhuber et al., 2024

View HTML @Full View
Document ID
9597930543992428754
Author
Muckenhuber M
Mengrelis K
Weijler A
Steiner R
Kainz V
Buresch M
Regele H
Derdak S
Kubetz A
Wekerle T
Publication year
Publication venue
Nature Communications

External Links

Snippet

The efficacy of costimulation blockade with CTLA4-Ig (belatacept) in transplantation is limited due to T cell-mediated rejection, which also persists after induction with anti- thymocyte globulin (ATG). Here, we investigate why ATG fails to prevent costimulation …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons

Similar Documents

Publication Publication Date Title
Park et al. Interleukin-10 produced by myeloid-derived suppressor cells is critical for the induction of Tregs and attenuation of rheumatoid inflammation in mice
Lückel et al. IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis
Hettwer et al. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis
Mao et al. Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism
Huynh et al. Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection
Puelles et al. mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans
Karki et al. NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer
Liu et al. Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways
Hill et al. Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma
Wang et al. Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity
Singh et al. Interleukin-35 administration counteracts established murine type 1 diabetes–possible involvement of regulatory T cells
Yan et al. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4+ CD25+ Foxp3+ regulatory T cells
Ishii et al. Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients
Kurdi et al. Tiam1/Rac1 complex controls Il17a transcription and autoimmunity
Li et al. Regulatory T cells control toxicity in a humanized model of IL-2 therapy
Jin et al. Interleukin‐7 enhances the Th1 response to promote the development of Sjögren's syndrome–like autoimmune exocrinopathy in mice
Riedel et al. IL-17F promotes tissue injury in autoimmune kidney diseases
Deng et al. Extrafollicular CD4+ TB interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease
Betts et al. The impact of regulatory T cells on carcinogen-induced sarcogenesis
Lee et al. Inhibition of IL-17 ameliorates systemic lupus erythematosus in Roquinsan/san mice through regulating the balance of TFH cells, GC B cells, Treg and Breg
Tanaka et al. Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6
Roddy et al. Tocilizumab for steroid refractory acute graft-versus-host disease
Summers et al. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane
Blume et al. Autoimmunity in CD73/Ecto-5′-nucleotidase deficient mice induces renal injury
Scheffler et al. LAMTOR2 regulates dendritic cell homeostasis through FLT3-dependent mTOR signalling